Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients (Q29364500)

12

0 references

Claus Svarer

8

0 references

Steven Haugbøl

5

0 references

Vibe Gedsø Frøkjær

4

0 references

David Erritzøe

1

0 references

Lars Hageman Pinborg

6

0 references

William F. C. Baaré

7

0 references

Henrik Lublin

10

0 references

Jacob Madsen

9

0 references

author name string

Hans Rasmussen

2

0 references

Klaus T Kristiansen

The role of serotonin in the pathophysiology and treatment of schizophrenia

3

0 references

language of work or name

English

0 references

publication date

20 February 2008

0 references

number of pages

7

0 references

published in

Neuropsychopharmacology

0 references

volume

33

0 references

issue

10

0 references

page(s)

2435-2441

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Decreased frontal cortical serotonin2A receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Serotonin2 receptors and the serotonin transporter in the schizophrenic brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Quetiapine Addition in Obsessive-Compulsive Disorder: Is Treatment Outcome Affected by Type and Dose of Serotonin Reuptake Inhibitors?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Alterations in the cortical serotonergic system in schizophrenia: A postmortem study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Obsessive-compulsive symptoms in schizophrenia: prevalance and clinical correlates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

5-HT2A and muscarinic receptors in schizophrenia: a postmortem study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

A nonparametric method for automatic correction of intensity nonuniformity in MRI data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

MR-based automatic delineation of volumes of interest in human brain PET images using probability maps

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

Tritiated LSD Binding in Frontal Cortex in Schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301656

7 January 2021